BioInvent extends collaboration for the discovery and development of ... Fort Mills Times BioInvent International AB (OMXS: BINV) today announces that it has signed an extension to its 2009 license agreement with Mitsubishi Tanabe Pharma Corporation for the development of antibodies from BioInvent's n-CoDeRĀ® library. Under the terms of the ... |
